{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:29:49Z","timestamp":1786696189449,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05366-0","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:10:30Z","timestamp":1773043830000},"page":"4647-4660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transarterial chemoembolization with prophylactic right inferior phrenic artery embolization for hepatocellular carcinoma in segments VII and VIII"],"prefix":"10.1007","volume":"51","author":[{"given":"Chao","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hua","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"23","key":"5366_CR1","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.3390\/cancers16234059","volume":"16","author":"K Krupa","year":"2024","unstructured":"Krupa K, Fudalej M, Cencelewicz-Lesikow A, et al. Current Treatment Methods in Hepatocellular Carcinoma. Cancers (Basel) 2024;16(23):4059. https:\/\/doi.org\/10.3390\/cancers16234059.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5366_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41392-022-01235-0","volume":"8","author":"HD Zhu","year":"2023","unstructured":"Zhu HD, Li HL, Huang MS, et al. Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001). Signal Transduct Target Ther 2023;8(1):58. https:\/\/doi.org\/10.1038\/s41392-022-01235-0.","journal-title":"Signal Transduct Target Ther"},{"issue":"18","key":"5366_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038037","volume":"103","author":"J Feng","year":"2024","unstructured":"Feng J, Zhao Y, Zhai L, et al. Efficacy and safety of transarterial chemoembolization combined with targeted therapy and immunotherapy versus with targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2024 ;103(18):e38037. https:\/\/doi.org\/10.1097\/MD.0000000000038037.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"5366_CR4","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.jhep.2022.07.019","volume":"77","author":"J Calderaro","year":"2022","unstructured":"Calderaro J, Di Tommaso L, Maill\u00e9 P, Beaufr\u00e8re A, et al. Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma. J Hepatol. 2022 Dec;77(6):1586-1597. https:\/\/doi.org\/10.1016\/j.jhep.2022.07.019.","journal-title":"J Hepatol."},{"issue":"10","key":"5366_CR5","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1007\/s00330-021-07905-x","volume":"31","author":"I Bargellini","year":"2021","unstructured":"Bargellini I, Lorenzoni V, Lorenzoni G, et al. Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-na\u00efve patients: a propensity score matching analysis. Eur Radiol 2021;31(10):7512-7522. https:\/\/doi.org\/10.1007\/s00330-021-07905-x.","journal-title":"Eur Radiol"},{"issue":"3","key":"5366_CR6","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1148\/rg.2017160122","volume":"37","author":"AS Moustafa","year":"2017","unstructured":"Moustafa AS, Abdel Aal AK, Ertel N, et al. Chemoembolization of Hepatocellular Carcinoma with Extrahepatic Collateral Blood Supply: Anatomic and Technical Considerations. Radiographics 2017;37(3):963-977. https:\/\/doi.org\/10.1148\/rg.2017160122.","journal-title":"Radiographics"},{"issue":"1","key":"5366_CR7","doi-asserted-by":"publisher","DOI":"10.1148\/rg.220076","volume":"43","author":"HC Kim","year":"2023","unstructured":"Kim HC, Miyayama S, Choi JW, et al. Hepatocellular Carcinoma Supplied by the Inferior Phrenic Artery or Cystic Artery: Anatomic and Technical Considerations. Radiographics 2023;43(1):e220076. https:\/\/doi.org\/10.1148\/rg.220076.","journal-title":"Radiographics"},{"issue":"4","key":"5366_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3348\/kjr.2006.7.4.257","volume":"7","author":"JW Chung","year":"2006","unstructured":"Chung JW, Kim HC, Yoon JH, et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Radiol 2006;7(4):257-66. https:\/\/doi.org\/10.3348\/kjr.2006.7.4.257.","journal-title":"Korean J Radiol"},{"issue":"3","key":"5366_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00270-009-9697-1","volume":"33","author":"S Miyayama","year":"2010","unstructured":"Miyayama S, Yamashiro M, Okuda M, et al. The march of extrahepatic collaterals: analysis of blood supply to hepatocellular carcinoma located in the bare area of the liver after chemoembolization. Cardiovasc Intervent Radiol 2010 ;33(3):513-22. https:\/\/doi.org\/10.1007\/s00270-009-9697-1.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"5366_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00270-007-9236-x","volume":"31","author":"A Basile","year":"2008","unstructured":"Basile A, Tsetis D, Montineri A, et al. MDCT anatomic assessment of right inferior phrenic artery origin related to potential supply to hepatocellular carcinoma and its embolization. Cardiovasc Intervent Radiol 2008;31(2):349-58. https:\/\/doi.org\/10.1007\/s00270-007-9236-x.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"5366_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/535272","volume":"2013","author":"L Yang","year":"2013","unstructured":"Yang L, Zhang XM, Ren YJ, et al. The features of extrahepatic collateral arteries related to hepatic artery occlusion and benefits in the transarterial management of liver tumors.\u00a0Radiol Res Prac\u00a02013;2013:535272. https:\/\/doi.org\/10.1155\/2013\/535272.","journal-title":"Radiol Res Prac"},{"issue":"6","key":"5366_CR12","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.3892\/etm.2015.2822","volume":"10","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Fang Z, Luo J, et al. Evaluation of extrahepatic collateral arteries in hepatocellular carcinoma in three independent groups in a single center. Exp Ther Med 2015;10(6):2366-2374. https:\/\/doi.org\/10.3892\/etm.2015.2822.","journal-title":"Exp Ther Med"},{"issue":"1","key":"5366_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12876-022-02110-6","volume":"22","author":"JS Kim","year":"2022","unstructured":"Kim JS, Lee HN, Lee WH, et al. Diaphragmatic perforation after transcatheter arterial chemoembolization of hepatocellular carcinoma via inferior phrenic artery: a case report. BMC Gastroenterol 2022;22(1):46. https:\/\/doi.org\/10.1186\/s12876-022-02110-6.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"5366_CR14","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/diagnostics12040834","volume":"12","author":"M Renzulli","year":"2022","unstructured":"Renzulli M, Brandi N, Pecorelli A, et al. Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers. Diagnostics (Basel) 2022;12(4):834. https:\/\/doi.org\/10.3390\/diagnostics12040834.","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"5366_CR15","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.1002\/hep.32801","volume":"82","author":"ML Schilsky","year":"2025","unstructured":"Schilsky ML, Roberts EA, Bronstein JM, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology 2025;82(3):E41-E90. https:\/\/doi.org\/10.1002\/hep.32801.","journal-title":"Hepatology"},{"key":"5366_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) as sessment for hepatocellular carcinoma. Semin Liver Dis 30:52\u201360. Feb;30(1):52-60. https:\/\/doi.org\/10.1055\/s-0030-1247132.","journal-title":"Semin Liver Dis"},{"key":"5366_CR17","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Bethesda, MD: National Cancer Institute; 2017. Available from:\u00a0https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm."},{"issue":"1","key":"5366_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jvir.2022.10.011","volume":"34","author":"MO Baerlocher","year":"2023","unstructured":"Baerlocher MO, Nikolic B, Sze DY. Adverse Event Classification: Clarification and Validation of the Society of Interventional Radiology Specialty-Specific System. J Vasc Interv Radiol. 2023;34(1):1-3. https:\/\/doi.org\/10.1016\/j.jvir.2022.10.011.","journal-title":"J Vasc Interv Radiol."},{"issue":"9","key":"5366_CR19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5807","volume":"11","author":"M Ertreo","year":"2019","unstructured":"Ertreo M, Swerdlow DR, Kim A, et al. Extrahepatic Vascular Parasitization by a Hepatocellular Carcinoma. Cureus 2019;11(9):e5807. https:\/\/doi.org\/10.7759\/cureus.5807.","journal-title":"Cureus"},{"issue":"12","key":"5366_CR20","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.ejrad.2015.10.006","volume":"84","author":"Q Li","year":"2015","unstructured":"Li Q, Ao GK, Duan F, et al. Incidence and therapeutic frequency of extrahepatic collateral arteries in transcatheter arterial chemoembolization of hepatocellular carcinoma: Experience from 182 patients with survival time more than 3 years. Eur J Radiol 2015;84(12):2555-63. https:\/\/doi.org\/10.1016\/j.ejrad.2015.10.006.","journal-title":"Eur J Radiol"},{"issue":"17","key":"5366_CR21","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.3748\/wjg.v11.i17.2637","volume":"11","author":"YL Wang","year":"2005","unstructured":"Wang YL, Li MH, Cheng YS, et al. Influential factors and formation of extrahepatic collateral artery in unresectable hepatocellular carcinoma. World J Gastroenterol 2005;11(17):2637-42. https:\/\/doi.org\/10.3748\/wjg.v11.i17.2637.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"5366_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3348\/kjr.2023.0385","volume":"24","author":"Y Cho","year":"2023","unstructured":"Cho Y, Choi JW, Kwon H, et al. Research Committee of the Korean Liver Cancer Association. Transarterial Chemoembolization for Hepatocellular Carcinoma: 2023 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association. Korean J Radiol 2023;24(7) :606-625. https:\/\/doi.org\/10.3348\/kjr.2023.0385.","journal-title":"Korean J Radiol"},{"issue":"34","key":"5366_CR23","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.3760\/cma.j.cn112137-20230630-01114","volume":"103","author":"Clinical Guidelines Committee of Chinese College of Interventionalists","year":"2023","unstructured":"Clinical Guidelines Committee of Chinese College of Interventionalists. [Chinese clinical practice guidelines for transarterial chemoembolization of hepatocellular carcinoma (2023 edition)]. Zhonghua Yi Xue Za Zhi 2023;103(34):2674-2694.https:\/\/doi.org\/10.3760\/cma.j.cn112137-20230630-01114.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"8","key":"5366_CR24","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jamasurg.2024.1228","volume":"159","author":"WA Preston","year":"2024","unstructured":"Preston WA, Collins ML, G\u00f6nen M, et al. Hemorrhage Sites and Mitigation Strategies After Pancreaticoduodenectomy. JAMA Surg 2024;159(8):891-899. https:\/\/doi.org\/10.1001\/jamasurg.2024.1228.","journal-title":"JAMA Surg"},{"issue":"1","key":"5366_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42155-023-00360-3","volume":"6","author":"C Ini'","year":"2023","unstructured":"Ini' C, Distefano G, Sanfilippo F, et al. Embolization for acute nonvariceal bleeding of upper and lower gastrointestinal tract: a systematic review. CVIR Endovasc 2023;6(1):18. https:\/\/doi.org\/10.1186\/s42155-023-00360-3.","journal-title":"CVIR Endovasc"},{"issue":"6","key":"5366_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2017.28","volume":"8","author":"K Liu","year":"2017","unstructured":"Liu K, Zhang X, Xu W, et al. Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply. Clin Transl Gastroenterol 2017;8(6):e98. https:\/\/doi.org\/10.1038\/ctg.2017.28.","journal-title":"Clin Transl Gastroenterol"},{"issue":"8","key":"5366_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071942","volume":"8","author":"GW Chen","year":"2013","unstructured":"Chen GW, Song B, Li ZL, et al. Ectopic blood supply of hepatocellular carcinoma as depicted by angiography with computed tomography: associations with morphological features and therapeutic history. PLoS One 2013;8(8):e71942. https:\/\/doi.org\/10.1371\/journal.pone.0071942.","journal-title":"PLoS One"},{"issue":"7","key":"5366_CR28","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jvir.2011.03.005","volume":"22","author":"HT Hu","year":"2011","unstructured":"Hu HT, Kim JH, Lee LS, et al. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. J Vasc Interv Radiol 2011;22(7):917-23. https:\/\/doi.org\/10.1016\/j.jvir.2011.03.005.","journal-title":"J Vasc Interv Radiol"},{"key":"5366_CR29","doi-asserted-by":"publisher","first-page":"1413696","DOI":"10.3389\/fphar.2024.1413696","volume":"15","author":"Z He","year":"2024","unstructured":"He Z, Zhang X, Zhang Y, et al. Locoregional interventional therapy for hepatocellular carcinoma: radiologic and clinical factors predictive of untreatable progression and time to untreatable progression. Front Pharmacol 2024 ;15:1413696. https:\/\/doi.org\/10.3389\/fphar.2024.1413696.","journal-title":"Front Pharmacol"},{"issue":"4","key":"5366_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.15403\/jgld.2014.1121.274.fcr","volume":"27","author":"R Cerban","year":"2018","unstructured":"Cerban R, Ester C, Iacob S, et al. Predictive Factors of Tumor Recurrence and Survival in Patients with Hepatocellular Carcinoma treated with Transarterial Chemoembolization. J Gastrointestin Liver Dis 2018 ;27(4):409-417. https:\/\/doi.org\/10.15403\/jgld.2014.1121.274.fcr.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"21","key":"5366_CR31","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.12998\/wjcc.v10.i21.7275","volume":"10","author":"SW Lee","year":"2022","unstructured":"Lee SW, Peng YC, Lien HC, et al. Clinical values of Barcelona Clinic Liver Cancer subgroup and up-to-7 criteria in intermediate stage hepatocellular carcinoma with transcatheter arterial chemoembolization. World J Clin Cases 2022 ;10(21):7275-7284. https:\/\/doi.org\/10.12998\/wjcc.v10.i21.7275.","journal-title":"World J Clin Cases"},{"issue":"4","key":"5366_CR32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3348\/kjr.2014.15.4.464","volume":"15","author":"K Han","year":"2014","unstructured":"Han K, Kim JH, Yoon HM, et al. Transcatheter arterial chemoembolization for infiltrative hepatocellular carcinoma: clinical safety and efficacy and factors influencing patient survival. Korean J Radiol 2014;15(4):464-71. https:\/\/doi.org\/10.3348\/kjr.2014.15.4.464.","journal-title":"Korean J Radiol"},{"key":"5366_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejro.2018.08.010","volume":"5","author":"Y Watanabe","year":"2018","unstructured":"Watanabe Y, Tokue H, Taketomi-Takahashi A, et al. Imaging findings and complications of transcatheter interventional treatments via the inferior phrenic arteries in patients with hepatocellular carcinoma. Eur J Radiol Open 2018;5:171-176. https:\/\/doi.org\/10.1016\/j.ejro.2018.08.010.","journal-title":"Eur J Radiol Open"},{"issue":"2","key":"5366_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1148\/radiol.2412051209","volume":"241","author":"SW Shin","year":"2006","unstructured":"Shin SW, Do YS, Choo SW, et al. Diaphragmatic weakness after transcatheter arterial chemoembolization of inferior phrenic artery for treatment of hepatocellular carcinoma. Radiology 2006 ;241(2):581-8. https:\/\/doi.org\/10.1148\/radiol.2412051209.","journal-title":"Radiology"},{"issue":"4","key":"5366_CR35","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.21037\/qims-24-1166","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang H, Liu Z, et al. Evolution of transarterial chemoembolization-related liver abscess over time: a systematic review and meta-analysis. Quant Imaging Med Surg 2025;15(4):2707-2721. https:\/\/doi.org\/10.21037\/qims-24-1166.","journal-title":"Quant Imaging Med Surg"},{"issue":"11","key":"5366_CR36","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.jvir.2016.04.034","volume":"27","author":"RP Lokken","year":"2016","unstructured":"Lokken RP, Fidelman N, Kolli KP, et al. Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral Arteries. J Vasc Interv Radiol. 2016 ;27(11):1698-1704. https:\/\/doi.org\/10.1016\/j.jvir.2016.04.034.","journal-title":"J Vasc Interv Radiol."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05366-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05366-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05366-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:02:55Z","timestamp":1786694575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05366-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5366"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05366-0","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}